CD5 and acute lymphoblastic leukemia: In this study, a significant association was seen between CD 34 negative B-ALL and expression of one or more aberrant immunophenotypic markers (CD13 + CD 33 + CD5 + CD7 + CD11b) (p=0.025) (Table 1).